News

August 1, 2008 - Osmetech said this week at the American Association for Clinical Chemistry (AACC) 2008 Conference and Exhibition in Washington, D.C., that following receipt of its 510(k)...

July 22, 2008 - Osmetech today said it received FDA 510(k) clearance for its eSensor Warfarin Sensitivity Test to be used as an aid in the identification of patients at risk for increased...

July 22, 2008 - CyGene Laboratories Inc. this week is introducing StrokeScan, a genetic screening test aimed at identifying high risk individuals who have a family history of stroke,...

April 28, 2008 - Researchers at the University of Warwick have found a that the protein E-selectin is a marker for endothelial dysfunction and sub-clinical systemic inflammation, which can help...

April 3, 2008 - Corgenix Medical Corp. has entered into an agreement with Randox Laboratories, a UK-based diagnostic company, in a partnership designed to expand the processing technology and...

March 20, 2008 - ARUP Laboratories and the University of Utah's Department of Pathology have released ARUP Consult version 2.3, a free laboratory test selection support tool for PDA devices that...

September 19, 2007 - Polymer Technology Systems Inc. (PTS) announced the availability of a new PTS Panels Test Strip to test important risk factors for cardiovascular disease and diabetes.

August 14, 2007 - Baseline serum complement component C4 is among independent predictors of stroke in patients with known or suspected coronary artery disease.

July 18, 2007 - In a related study of over 25,000 initially healthy women, higher triglyceride levels measured after not fasting is associated with an increased risk for cardiovascular events, but...

June 18, 2007 – BioServe today announced that it has been selected by Houston-based Specialized Clinical Center of Research (SCCOR) for a novel study aimed at identifying the genetic cause of...

June 4, 2007 — Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...